Home Blog Page 78

Blog

Pharma Marketing Blog

Most popular

Tom Stossel Attempts to Debunk the Conflict-of-Interest “Myth”

Pharma Guy - May 20, 2015

Questions I Hope AZ Can Answer During Tonight’s #rxsave Twitter Chat

Pharma Guy - February 16, 2011

Speaking of Sanofi: A Blog for Pharma Aficionados

Pharma Guy - December 7, 2012

Pfizer has a Gold Mine in Sermo!

Pharma Guy - October 16, 2007

Do Pharma Marketers Need a Thick Skin or Will a...

Pharma Guy - September 10, 2007

PhRMA Intern vs. the Pharma PR Agency!

Pharma Guy - July 24, 2006

WSJ Cites PM Blog as “Must Read”

Pharma Guy - November 16, 2005

Unsafe Drugs: Is It Counterfeiters or the Supply Chain That’s the...

Pharma Guy - August 4, 2010

Blog Readers’ Opinions on Physician Marketing & Education Practices

Pharma Guy - May 15, 2007

The $400 Million bapi Drug Failure: Are Patient Advocates the Scapegoat?

Pharma Guy - August 17, 2012

1...777879...240 Page 78 of 240

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Researcher analyzing genetic data for an ultra-rare disease alongside physicians, DNA imagery, and patient silhouettes representing rare disease awareness and patient identification.

How Do You Market a Disease That Doesn’t Officially Exist?

August 6, 2026

Healthcare professional reviewing a plain-language clinical trial summary with a patient, illustrating how transparent communication strengthens trust, patient engagement, and pharmaceutical marketing.

The Plain-Language Revolution: How Compliance Is Becoming a Marketing Advantage

August 5, 2026

Healthcare professional reviewing a personalized medication dosing plan, illustrating flexible dosing strategies that support patient persistence and individualized treatment.

Could Flexible Dosing Become Pharma’s Next Competitive Advantage?

August 4, 2026